Euro
USD
British Pound
NULL
Product Description
SARS-CoV-2 Spike protein is a large type I transmembrane protein composed of S1 subunit and S2 subunit. During viral infection, the receptor-binding domain (RBD) of the S1 subunit is responsible for the recognition and binding of host receptor ACE2, while the S2 subunit mediates viral cell membrane fusion. The SARS-CoV-2-S1-RBD/ACE2 interaction mediates viral entry into the target cells. The N501Y mutation in the receptor-binding domain (RBD) of SARS-CoV-2 variants increases binding affinity to ACE2.
Biovision | P1644 | Human CellExp™ SARS-CoV-2 Spike RBD (N501Y), Recombinant DataSheet
Biomolecule/Target :
Synonyms: COVID-19 Spike RBD protein (N501Y); 2019-nCoV Spike RBD protein (N501Y); SARS-CoV-2 Mutant (N501Y); SARS-CoV-2 (N501Y) mutant protein
Alternates names: COVID-19 Spike RBD protein (N501Y); 2019-nCoV Spike RBD protein (N501Y); SARS-CoV-2 Mutant (N501Y); SARS-CoV-2 (N501Y) mutant protein
Taglines: Spike RBD (N501Y) mutant increases binding affinity to ACE2
NCBI Gene ID #:
NCBI Gene Symbol:
Gene Source: Coronavirus
Accession #: QHD43416.1
Recombinant: 1
Source: Human cells
Purity by SDS-PAGE: ≥ 95% by SDS-PAGE
Assay:
Purity:
Assay #2:
Endotoxin Level:
Activity (Specifications/test method):
Biological activity:
Results:
Binding Capacity:
Unit Definition:
Molecular Weight: The predicted molecular weight is 26 kDa. The protein migrates as a 33-36 kDa band under reducing conditions
Concentration:
Appearance: Liquid
Physical form description:
Reconstitution Instructions:
Amino acid sequence: The target protein is expressed with the sequence Arg319-Ser541(N501Y) of SARS-CoV-2 Spike RBD protein fused with a 6xHis tag at the C-terminus.
Handling: Centrifuge the vial prior to opening.
Usage: For Research Use Only! Not to be used in humans
